Biblio
Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting. Exp Hematol Oncol. 2023;12(1):57.
Bioactive mesoporous silica nanoparticle-functionalized titanium implants with controllable antimicrobial peptide release potentiate the regulation of inflammation and osseointegration. Biomaterials. 2024;305:122465.
. Case report: Venetoclax plus Azacitidine in treatment of acute undifferentiated leukemia. Hematology. 2024;29(1):2293494.
. Integrative Multi-omics Analysis Identifies Genetic Variants Contributing to Non-syndromic Cleft Lip with or without Cleft Palate. Chin J Dent Res. 2024;27(1):65-73.
. LINC MIR503HG Controls SC-β Cell Differentiation and Insulin Production by Targeting CDH1 and HES1. Adv Sci (Weinh). 2024:e2305631.
Mangiferin improves early porcine embryonic development by reducing oxidative stress. Reprod Domest Anim. 2024;59(4):e14565.
. Mechanical Stretch-Induced ATP Release from Osteocytes Promotes Osteogenesis of Bone Marrow Mesenchymal Stem Cells. Discov Med. 2024;36(182):494-508.
. The role of genetic factors in pediatric myelodysplastic syndromes with different outcomes. BMC Pediatr. 2024;24(1):28.
. Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting. Exp Hematol Oncol. 2024;13(1):17.